Drugmakers can keep making off-brand weight-loss drugs as FDA backpedals
Facing a lawsuit, the Food and Drug Administration has decided to reconsider its decision to take popular weight-loss and diabetes drugs off of the national shortage list, which will allow compounding ...
FDA says compounding pharmacies can keep making weight-loss med tirzepatide, for now
Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug ...
FDA shakes up weight loss market as Mounjaro shortage ends
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...
FDA will reconsider decision barring copycat versions of Lilly weight loss drug
The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...
Premiums this year may surprise you: Why health insurance is getting more expensive
Escalating grocery bills and car prices have cooled, but price relief for Americans does not extend to health care, a new ...
HealthLeaders Media2d
Part 2: How Those Hot New Employer Cost Stats Could Upend Employers' Payer-PBM Relationships
For everything from GLP-1 and cancer costs to provider networks, one employer association has strategies — and they don't ...
MarketWatch4d
4 things you need to know about Medicare drug costs and coverage in 2025
The changes coming with the new year — including a lower cap on out-of-pocket prescription-drug costs and a new program designed to help enrollees spread out their medication costs over the ...